LIN SUE-JEAN 4
4 · Arcutis Biotherapeutics, Inc. · Filed Jun 2, 2023
Insider Transaction Report
Form 4
LIN SUE-JEAN
Director
Transactions
- Award
Stock Option (right to buy)
2023-05-31+12,220→ 12,220 totalExercise: $7.51Exp: 2033-05-31→ Common Stock (12,220 underlying) - Award
Common Stock
2023-05-31+4,375→ 8,987 total
Footnotes (2)
- [F1]Includes 4,375 Restricted Stock Units (?RSUs?). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.
- [F2]The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023.